Today, INSYS Therapeutics (INSY) is trading at $4.69, up ~8.80% from its close of $4.31 on January 16. On January 16, INSY rose ~2.62% to $4.31 from its previous close of $4.20 on January 15.
INSYS Therapeutics stock has risen from $3.50 at the close of market on December 31, 2018, to $4.66 today, which represents a 34% rise to date in January. To learn more about INSYS Therapeutics stock, read Cannabis Stock INSYS Therapeutics Is on the Rise in January.
Today, GW Pharmaceuticals (GWPH) is trading at $132.89, up ~3.33% from its close of $128.61 on January 16. On January 15, the stock rose ~3.72% to $128.54 from its previous day’s close of $123.93.
GW Pharmaceuticals stock closed at $97.39 on December 31, 2018, and it’s trading at $132.89 today, which reflects a rise of ~36% to date in January. To learn more about GW Pharmaceuticals stock, read Cannabis Stock GW Pharmaceuticals Growing Steadily in January.
Today, Canopy Growth (CGC) is trading at $43.36 on the NYSE, up ~3.0% from its close of $42.10 on January 16. On January 14, GCC rose ~11.08% to $42.49 from its close of $38.25 on January 11.
Canopy Growth recently received a hemp license from the State of New York. The approval of the license will help the company establish its Hemp Industrial Park, which is expected to boost its revenue growth.
Today, the Horizons Marijuana Life Sciences Index ETF (HMLSF) and the ETFMG Alternative Harvest ETF (MJ), which track cannabis stocks, are in the green with rises of 0.48% and 0.10%, respectively.
Canopy Growth and GW Pharmaceuticals make up ~13.11% and 9.14% of HMLSF, respectively. Canopy Growth, GW Pharmaceuticals, and INSYS Therapeutics make up ~10.11%, ~5.95%, and ~1.64% of MJ, respectively.